GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (TSX:BHC) » Definitions » Cash Receipts from Operating Activities

Bausch Health (TSX:BHC) Cash Receipts from Operating Activities


View and export this data going back to 1987. Start your Free Trial

What is Bausch Health Cash Receipts from Operating Activities?

Cash Receipts from Operating Activities only applicable to companies reporting Cash Flow from Operations in direct method.


Bausch Health Business Description

Industry
Traded in Other Exchanges
Address
2150 St Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
Executives
Seana Lynne Carson Senior Officer
Joseph Papa Director, Senior Officer
Andrew Charles Von Eschenbach Director
Robert Allen Spurr Senior Officer
Joseph Gordon Senior Officer
Steven Daniel Miller Director
Richard Urbain De Schutter Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Osama Eldessouky Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Amy Wechsler Director
William Douglas Humphries Senior Officer
John Paulson Director
Thomas Ross Sr. Director
Christina Ackermann Senior Officer
Paul Herendeen Senior Officer